Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Baxter
QuintilesIMS
Deloitte
Dow
Cipla
Julphar
Healthtrust

Generated: August 15, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,888,364

« Back to Dashboard

Which drugs does patent 7,888,364 protect, and when does it expire?

Patent 7,888,364 protects ERIVEDGE and is included in one NDA.

This patent has forty-three patent family members in twenty-two countries.

Summary for Patent: 7,888,364
Title:Pyridyl inhibitors of hedgehog signalling
Abstract: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: ##STR00001## wherein A, X, Y R.sub.1, R.sub.2, R.sub.3, R.sub.4, m and n are as described herein.
Inventor(s): Gunzner; Janet L. (Berkeley, CA), Sutherlin; Daniel (South San Francisco, CA), Stanley; Mark S. (Pacifica, CA), Bao; Liang (San Mateo, CA), Castanedo; Georgette M. (Redwood City, CA), Lalonde; Rebecca L. (Berkeley, CA), Wang; Shumei (Foster City, CA), Reynolds; Mark E. (Millbrae, CA), Savage; Scott J. (Burlingame, CA), Malesky; Kimberly (San Francisco, CA), Dina; Michael S. (Daly City, CA)
Assignee: Curis, Inc. (Cambridge, MA)
Application Number:11/217,663
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 7,888,364

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech ERIVEDGE vismodegib CAPSULE;ORAL 203388-001 Jan 30, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,888,364

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,278,961 Pyridyl inhibitors of hedgehog signalling ➤ Try a Free Trial
9,790,183 Pyridyl inhibitors of hedgehog signalling ➤ Try a Free Trial
9,321,761 Pyridyl inhibitors of hedgehog signalling ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,888,364

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand 589385 ➤ Try a Free Trial
Norway 339260 ➤ Try a Free Trial
Norway 20071719 ➤ Try a Free Trial
Mexico 2007002584 ➤ Try a Free Trial
Luxembourg 92278 ➤ Try a Free Trial
South Korea 20170001725 ➤ Try a Free Trial
South Korea 20160058972 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Medtronic
Mallinckrodt
US Department of Justice
UBS
Cerilliant
QuintilesIMS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.